Relapsed or Refractory CD19+/BCMA+ Hematologic Malignancies
1 clinical trials · Condition
◉ Watch Relapsed or Refractory CD19+/BCMA+ Hematologic Malignancies
| Record | Firm | Date |
|---|---|---|
| RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies (NCT07113496) | The First Affiliated Hospital with Nanjing Medical University | 2025-08-01 |
Track Relapsed or Refractory CD19+/BCMA+ Hematologic Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.